Biopharmaceuticals
News Release - October 27, 2006
Roche Oral Polymerase Inhibitor R1626 Shows Strong Antiviral Activity in Chronic Hepatitis C Patients in Early Trial
Source: Roche
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.